Ottawa has been pouring billions of dollar annually into both private-sector and university-based research that, it argues, serves the public’s interest by working to develop the next best “thing.” In this formulation of the public’s interest, public money is used to subsidize about 90 per cent of the costs associated with research that aims to generate privately owned intellectual properties, like a ground-breaking cancer-busting drug for example, that the public then gets to buy at tremendous expense. Apparently, if the public agrees to pay twice, corporations will invest in and grow Canada’s economy. So scarce resources are being pulled from the kind of research that does not have any obvious or immediate commercial interest and directed to those research programs that have precisely that potential.
Pressing Refresh Notes:
Couldn’t have said it better!